As a gynecologic oncologist, Dr. Diljeet Singh is on the front
lines treating women with the devastating effects of cervical
cancer. So when a vaccine to prevent Human Papillomavirus (HPV),
which causes most cervical cancers, was approved for use in the
United States, she was thrilled.
"I'm an oncologist, so to me preventing cancer is key," says
Singh, co-director of the ovarian cancer early detection program at
Northwestern Memorial Hospital.
Dr. Diana Zuckerman also admits to being thrilled when Gardasil
was approved to vaccinate girls against HPV. Zuckerman, president
of the National Research Center for Women & Families in
Washington, D.C., says since then she has analyzed reams of
research and attended more meetings concerning the vaccine than she
can even describe.
for her and other staff members at her organization, whose sole
purpose is to provide unbiased analysis of current research, the
initial excitement has turned into skepticism about the wonders of
"We started out quite enthusiastic about Gardasil for girls.
We've become less enthusiastic because we think the manufacturer is
not being forthcoming about how long it lasts," Zuckerman says.
"And it's so expensive, the most expensive vaccine ever sold in
this country, so you want to make sure it lasts."
HPV is the name for a group of viruses that cause cervical
cancer and genital warts. There are more than 120 types of HPV and
as many as 40 of them are spread through sexual contact, according
to the National Research Center for Women & Families. Many of
the approximately 6 million people who are infected with genital
HPV each year in the United States have no symptoms and don't know
they are infected and 90 percent of cases clear up on their own
without treatment. Not all HPV causes cancer, but 99 percent of
cervical cancer can be traced to infection with a strain of
Controversy over the vaccines
The controversy over the safety and effectiveness of the HPV
vaccine has ramped up in recent months with the approval in the
U.S. of a second anti-cancer vaccine, Cervarix, and with the
Centers for Disease Control and Prevention's approval of Gardasil
for boys as well as girls.
Now parents of tweens and teens are slogging through Internet
research and discussions with doctors to decide whether or not to
vaccinate their children. At the same time, many doctors are wading
through the same onslaught of information for and against the
Angie Brocato of Darien remembers her doctor bringing up the
vaccine when she brought her daughter in for a checkup at age 12.
She'd done some research on the vaccine and decided she wasn't
ready to vaccinate her daughter without more information.
A year later, when she brought her daughter in for another
checkup, the discussion again turned to the HPV vaccine. But this
time it was her doctor who told Brocato that, based on what she had
heard about the vaccine, she couldn't in good conscience recommend
"We had basically said we weren't going to, I still don't think
we'll get it," Brocato remembers. "And she said that she wasn't
comfortable with it either at this point."
Brocato, who has a 13-year-old daughter and an 11-year-old son,
is just one of many parents who want to do the best thing to care
for their children, but who aren't sure what the right answer is.
However, many national organizations, such as the American Academy
of Pediatrics and the Centers for Disease Control, say the decision
is easy-the vaccines, both Cervarix and Gardasil, are not only safe
but can effectively eliminate the virus that causes almost all
cases of cervical cancer.
"This is a very clearly needed vaccine for adolescent girls,
reducing their lifetime risk of cervical cancer and it is very
important as a preventive measure for the health of all women,"
says Dr. Joseph Bocchini, chairperson of the AAP's committee on
infectious diseases and chairman of the Department of Pediatrics at
Louisiana State University Health Sciences Center in
Who's actually recommending?
But some parents, and experts, think Gardasil has been so
heavily marketed that a doctor's recommendation isn't enough to go
on when considering the vaccine for their children. Because
vaccines in the United States are created by companies whose goal
is to make a profit, it's not always easy to determine objectively
the value of a specific vaccine.
"Parents have to remember that people are selling this product
and, like any product that's being sold, people have a vested
interest in selling their product and making money and that puts
parents in a difficult spot when deciding," Zuckerman says.
"There's a lot of hype-the ads would make you think your daughter
will get cervical cancer unless she gets this vaccine. But cervical
cancer is still a pretty rare cancer in this country and the
vaccine is, at most, 70 percent effective and probably less over
How long does it last?
Part of the controversy with the HPV vaccines revolves around
how long the vaccines actually provide immunity. Because both
Gardasil and Cervarix have been around for less than 10 years, it's
not known if the immunity from HPV lasts indefinitely or if it
wanes over time. Glaxo, which manufactures Cervarix, has
distributed more than 7 million doses of the vaccine in other
countries and has tracked immunity for the 6.4 years since
vaccinations started. While they will continue to track immunity,
current research shows that immunity continues for at least that
length of time, says Jeff McLaughlin, spokesperson at Glaxo.
Merck, the manufacturer of Gardasil, has also tracked the
ongoing immunity provided by the vaccine. At this point Gardisal
shows immunity for five years, and ongoing studies will continue,
says Jennifer Allen Woodruff, spokesperson for Merck. In one study,
a challenge dose was given to women five years after receiving the
vaccine to check immune response. Woodruff says this dose is given
to check if immune memory is evident at that point because studies
can't expose women to the actual virus.
"We have seen what is called immune memory with Gardasil, and
that's considered to be a hallmark of long-term value for the
vaccine," Woodruff says. At this point there is no indication that
a booster shot would be needed, she says.
Zuckerman says it's not quite that clear-cut. "We're
particularly concerned about Gardasil, not Cervarix, because in the
one study Merck did about girls and young women, they gave a
challenge dose of the vaccine at 60 months and then they measured
their antibodies a short time later," she says. "To us, that looks
like a booster shot. ... At three years, it looks like some of the
protection is wearing off. In contrast, Cervarix is working longer
than six years."
But the AAP's Bocchini says it's not unusual for vaccine
immunity to wane over time. "These are new vaccines, so the thing
we don't know is how long the immune response will last to enable
the vaccines to remain effective," he says. "We have data out to at
least six years and the vaccines remain effective at least six
years, but longer than that we don't know. We don't know whether
immunity will be lifelong or will require a booster."
He says it's important to give the shot early, even if a booster
might be needed later. "It's really important to still give this
vaccine prior to the onset of sexual activity."
How long the vaccine lasts isn't the only concern for
Recent media reports about girls who contracted fatal or
debilitating illnesses such as Guillain-Barre Syndrome after
receiving the vaccine have created Internet storms as parents react
to the possibility that the vaccine isn't completely safe.
But many of the experts in favor of the vaccine point out that
no studies have linked GBS to the vaccine, and the number of people
contracting those illnesses are the same whether individuals are
vaccinated or not.
"Since we give this vaccine to large numbers of patients, when
an event occurs after vaccines, we have to determine if the vaccine
caused it or if it occurred by chance," Bocchini says. "At this
point, the events that have occurred have been at a frequency that
is no greater than we would expect in the general population.
Although we have to continue to monitor for safety issues, there is
no safety issue that has come up to cause concern about either
Singh also thinks cautionary stories in the media haven't stood
up to investigation.
"When most of these stories are really followed down, they
haven't clearly connected the vaccine to someone dying of
something," she says, noting that no vaccine comes without risk, so
the decision to vaccinate comes down to evaluating whether or not
the benefits outweigh the risks. When it comes to preventing
cancer, she says the benefits of either vaccine outweigh the
possibility of any rare complications.
Another part of the controversy, Singh says, involves the fact
that these vaccines are for sexually transmitted diseases, and many
parents of tweens aren't ready to tackle the issue of their
"The thing I find fascinating about this discussion, we give
Hepatitis B (vaccines) to babies when they're born. You get Hep B
from sex or needles. Nobody says, my baby's been vaccinated, that
means he or she will run out and have sex because she had (the
vaccine)," Singh says. But some parents don't want their children
to be overly confident about their level of protection from the
vaccine once they become sexually active.
Angie Brocato admits to thinking about future attitudes when
deciding whether to vaccinate her daughter. "I didn't want her to
have any kind of false security over so-called safe sex. I don't
want these girls to think they've got this shot and they're not
subject to gonorrhea or HIV, and this shot only takes care of a few
strands of one particular disease."
Zuckerman, who agrees the vaccines appear to prevent about 70
percent of HPVs, also notes that 30 percent of the viruses are not
covered. "At best, it's an imperfect vaccine."
With the recent approval of Gardasil for boys, parents need to
have even more discussions with their doctors. In October, the CDC
approved Gardasil for "permissive use" in males. It stopped short
of recommending it for boys, leaving the decision to parents and
doctors. Gardasil provides protection for boys from HPV-related
"If you vaccinate all girls and boys, yes, it'll cost twice as
much, but ... if you think about, that's how the virus is passed
around, you get herd immunity," Singh says. "And genital warts are
a drag. If we can affect boys' protection, why not? Plus it gets
rid of the stigma, of making it a girls' problem."
But the issue of how long the vaccine provides immunity is just
as critical for boys, Zuckerman says, and it makes the decision to
vaccinate even less clear-cut. "We don't think 12-year-old boys are
at a big risk of genital warts.
The risk gets a lot higher when they get older," she says. "We
don't think most families are going to want to vaccinate their
boys, at $400 a vaccine every few years, to protect against genital
Making the decision
While some other states have mandated the vaccine, in Illinois
the decision to vaccinate comes down to the parent's choice.
Deciding whether to vaccinate using Gardasil or Cervarix also rests
with parents and their doctors.
While the AAP recommends children receive the vaccine at ages 11
or 12, Zuckerman says a wait-and-see approach regarding the
vaccines won't hurt.
"For those who are a little concerned and would like to know
more before they vaccinate, it appears that delaying vaccination
for a few years is not a really big problem, but a sexually active
teen should get pap smears."
All the experts agree that whether children are vaccinated or not,
pap smears, once they become sexually active, remain a key element
in preventing cervical cancer and shouldn't be overlooked in the
fight against the disease.
Singh also recommends that parents who aren't getting the
answers they need from their pediatrician regarding the vaccines
should continue to ask the questions until they're comfortable with
their decision. "Talk to your OB/GYN. Seek out other information,"
she says. "There's too much information out there in some ways, but
people can try to direct you towards good vaccination
Liz DeCarlo is the senior editor at Chicago Parent.
See more of Liz's stories here.
What to do with your weekend, delivered every Thursday.
Great deals and chances to win prizes, delivered every Monday.
Exclusive offers from our partners,usually delivered twice a week.
Resources for parents of children with special needs,delivered the second Tuesday each month.